CNAT

Conatus Pharmaceuticals Inc. Ownership Summary

$7.53
*  
0.22
2.84%
Get CNAT Alerts
*Delayed - data as of Mar. 30, 2015 12:36 ET  -  Find a broker to begin trading CNAT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CNAT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Institutional Ownership View CNAT Ownership

Institutional Summary

Institutional Holdings 22.85%
Total Number of Holders 42
Total Shares Held 3,585,618
Total Value of Holdings 27,788,540
Net Activity (348,531)


Top 5 Holders of Institutional Holdings

1. MPM ASSET MANAGEMENT LLC 1,192,080
2. AXA 517,636
3. POLAR CAPITAL LLP 250,000
4. PUTNAM INVESTMENTS LLC 217,762
5. VANGUARD GROUP INC 209,853


Insider Trades View CNAT Insider Trades

Insider Trades Summary


3 Mo. 12 Mo.
Number of Buys 0 0
Number of Sells 0 0
Total Insider Trades 0 0
Net Activity 0 0


Top 5 Insider Trades



Hover over columns for trade information
Buy / Sell

CNAT Ownership Overview


Conatus Pharmaceuticals Inc. (CNAT) Ownership Summary provides a snapshot of institutional holdings and activity for a particular stock. The institutional holdings summary data encompasses the holdings and change from most recent 13F filings. The insider filer data counts the number of monthly positions over 3 month and 12 month time spans. Summary data is calculated daily, using the most up to date information available.


info  Learn more about the Ownership Summary Page